Gabelli Funds’s PetMed Express PETS Stock Holding History

Gabelli Funds’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,279	Closed	-$419K	–	1124
2019 Q3	$419K	Buy	23,279 +6,479	+39%	+$107K	﹤0.01%	978
2019 Q2	$263K	Buy	16,800 +3,000	+22%	+$59K	﹤0.01%	1056
2019 Q1	$314K	Buy	13,800 +4,000	+41%	+$90.2K	﹤0.01%	1029
2018 Q4	$228K	Buy	+9,800	New	+$262K	﹤0.01%	1077

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Gabelli Funds's PETS Position: Q4 2019 in Review

Gabelli Funds sold out of PetMed Express (PETS) in Q4 2019, closing a stake of 23,279 shares — an estimated $419K sold.

Gabelli Funds first reported a position in PETS in Q4 2018 and held it in 4 quarters. The position peaked at $419K in Q3 2019. 189 funds tracked by Wall St. Rank hold PETS as of Q4 2019.

Gabelli Funds reported no remaining PetMed Express position as of Q4 2019 after selling out during the quarter.
Gabelli Funds sold 23,279 PetMed Express shares in Q4 2019, an estimated $419K.
Gabelli Funds first reported a position in PetMed Express in Q4 2018 and held it in 4 quarters.
Gabelli Funds's PetMed Express position peaked at $419K in Q3 2019.
189 funds tracked by Wall St. Rank held PetMed Express as of Q4 2019.

Based on Gabelli Funds's 13F filing for Q4 2019, filed 14 Feb 2020.